Liabilities and Equity in USD of THERALINK TECHNOLOGIES, INC. from Q1 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
THERALINK TECHNOLOGIES, INC. quarterly Liabilities and Equity history and change rate from Q1 2011 to Q4 2023.
  • THERALINK TECHNOLOGIES, INC. Liabilities and Equity for the quarter ending 31 Dec 2023 was $1.78M, a 45.1% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

THERALINK TECHNOLOGIES, INC. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.78M -$1.46M -45.1% 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 $2.85M +$251K +9.65% 30 Sep 2023 10-Q 20 Feb 2024
Q2 2023 $1.73M -$669K -28% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 $2.25M -$555K -19.8% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $3.25M +$501K +18.3% 31 Dec 2022 10-Q 21 Feb 2023
Q3 2022 $2.6M +$960K +58.6% 30 Sep 2022 10-K 05 Jan 2024
Q2 2022 $2.39M +$581K +32% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $2.8M +$1.2M +75.2% 31 Mar 2022 10-Q 23 May 2022
Q4 2021 $2.75M +$801K +41.2% 31 Dec 2021 10-Q 18 Feb 2022
Q3 2021 $1.64M -$1.56M -48.7% 30 Sep 2021 10-K 29 Dec 2022
Q2 2021 $1.81M -$435K -19.3% 30 Jun 2021 10-Q 28 Sep 2021
Q1 2021 $1.6M +$1.57M +5144% 31 Mar 2021 10-Q 27 Sep 2021
Q4 2020 $1.95M +$1.85M +1965% 31 Dec 2020 10-Q 27 Sep 2021
Q3 2020 $3.2M +$2.09M +190% 30 Sep 2020 10-K 13 Jan 2022
Q2 2020 $2.25M +$2.01M +834% 30 Jun 2020 10-Q 11 Jun 2021
Q1 2020 $30.5K -$234K -88.5% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $94.2K -$132K -58.4% 31 Dec 2019 10-Q 15 May 2020
Q3 2019 $1.1M +$814K +283% 30 Sep 2019 10-K 27 Sep 2021
Q2 2019 $241K +$209K +663% 30 Jun 2019 10-Q 15 Aug 2019
Q1 2019 $264K +$9.09K +3.56% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $227K +$199K +734% 31 Dec 2018 10-K 25 Mar 2020
Q3 2018 $288K -$110K -27.6% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $31.6K -$5.11M -99.4% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $255K -$4.92M -95.1% 31 Mar 2018 10-Q 19 Jun 2018
Q4 2017 $27.2K -$30.2K -52.6% 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 $398K +$324K +436% 30 Sep 2017 10-Q 20 Nov 2017
Q2 2017 $5.15M +$5.04M +4638% 30 Jun 2017 10-Q 14 Sep 2017
Q1 2017 $5.17M +$4.74M +1103% 31 Mar 2017 10-Q 22 May 2017
Q4 2016 $57.3K -$669K -92.1% 31 Dec 2016 10-K 31 May 2018
Q3 2016 $74.2K -$130K -63.8% 30 Sep 2016 10-Q 21 Nov 2016
Q2 2016 $109K +$98.2K +946% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $430K +$423K +6125% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 $727K +$626K +621% 31 Dec 2015 10-K 17 Apr 2017
Q3 2015 $205K -$135K -39.7% 30 Sep 2015 10-Q 16 Nov 2015
Q2 2015 $10.4K -$312K -96.8% 31 May 2015 10-Q 20 Jul 2015
Q1 2015 $6.91K -$342K -98% 28 Feb 2015 10-Q 20 Oct 2015
Q4 2014 $101K -$515K -83.6% 31 Dec 2014 10-K 13 Apr 2016
Q3 2014 $340K -$88.7K -20.7% 31 Aug 2014 10-Q 14 Oct 2014
Q2 2014 $323K -$166K -34% 31 May 2014 10-Q 21 Jul 2014
Q1 2014 $349K -$436K -55.5% 28 Feb 2014 10-K 29 May 2015
Q4 2013 $616K -$857K -58.2% 30 Nov 2013 10-Q 14 Jan 2014
Q3 2013 $428K -$1.42M -76.8% 31 Aug 2013 10-Q 17 Oct 2013
Q2 2013 $489K -$538K -52.4% 31 May 2013 10-Q 31 Jul 2013
Q1 2013 $786K -$343K -30.4% 28 Feb 2013 10-K 13 Jun 2014
Q4 2012 $1.47M +$444K +43.2% 30 Nov 2012 10-Q 22 Jan 2013
Q3 2012 $1.85M +$714K +63.1% 31 Aug 2012 10-Q 15 Oct 2012
Q2 2012 $1.03M 31 May 2012 10-Q 13 Jul 2012
Q1 2012 $1.13M -$420K -27.1% 29 Feb 2012 10-K 28 Jun 2013
Q4 2011 $1.03M 30 Nov 2011 10-Q 17 Jan 2012
Q3 2011 $1.13M 31 Aug 2011 10-Q 17 Oct 2011
Q1 2011 $1.55M 28 Feb 2011 10-K 18 May 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.